Business Standard

Thursday, January 09, 2025 | 08:38 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Rossari Biotech IPO subscribed 79.4 times, generates bids worth Rs 27K cr

Rossari is the first IPO to hit the domestic markets since a national lockdown was declared in early-March.

IPO, initial public offering
Premium

Given the high demand, the IPO is likely to be priced at the top-end of the price band of Rs 423-425 per share.

Sundar Sethuraman
Rossari Biotech has received 79.4 times the demand of shares on offer in its initial public offering (IPO), on Wednesday, which is the last day of the issue. The institutional investor portion of the IPO was subscribed more than 85 times, the wealthy investor portion subscribed 240 times, and the retail investor portion garnered 7.2 times subscription. 

The IPO saw over 600,000 application and generated bids worth over Rs 27,000 crore.

Given the high demand, the IPO is likely to be priced at the top-end of the price band of Rs 423-425 per share. At the top end, the company commands a

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in